Benjamin Gomez-Navarro

Prof. Dr. Benjamin Gomez-Navarro


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Human Immunology
Verified
Journal Article
Closed access
IGIsis Goné-Vázquez
Isis Goné-Vázquez
RBRodrigo Barquera
Rodrigo Barquera
FAFrancia Paulina Arellano-Prado
Francia Paulina Arellano-Prado
DHDiana Iraíz Hernández-Zaragoza
Diana Iraíz Hernández-Zaragoza
AEAraceli Escobedo-Ruíz
Araceli Escobedo-Ruíz
JGJulio Granados
Julio Granados

1 September 2020 in Human Immunology
Verified
Journal Article
Closed access
SCStephen Clayton
Stephen Clayton
RBRodrigo Barquera
Rodrigo Barquera
MUMaría Guadalupe Uribe-Duarte
María Guadalupe Uribe-Duarte
IVIsis Goné Vázquez
Isis Goné Vázquez
JZJoaquín Zúñiga
Joaquín Zúñiga
JGJulio Granados
Julio Granados

1 September 2020 in Human Immunology
Verified
Journal Article
Closed access
MBMónica Ballesteros-Romero
Mónica Ballesteros-Romero
RBRodrigo Barquera
Rodrigo Barquera
MRMarla Estefanía Rodríguez-López
Marla Estefanía Rodríguez-López
DHDiana Iraíz Hernández-Zaragoza
Diana Iraíz Hernández-Zaragoza
IGIsis Goné-Vázquez
Isis Goné-Vázquez
VRVictor Daniel Acuña Rocha
Victor Daniel Acuña Rocha

1 September 2020 in Human Immunology
Verified
Journal Article
Open access
AEAraceli Escobedo-Ruíz
Araceli Escobedo-Ruíz
RBRodrigo Barquera
Rodrigo Barquera
AGAntonio González-Martín
Antonio González-Martín
JMJuan Manuel Argüelles-San Millán
Juan Manuel Argüelles-San Millán
MUMaría Guadalupe Uribe-Duarte
María Guadalupe Uribe-Duarte
JGJulio Granados
Julio Granados
We studied HLA class I (HLA-A, -B) and class II (HLA-DRB1, -DQB1) alleles by PCR-SSP based typing in 250 Mexicans from the states of Baja California Norte and Baja California Sur living in Mexicali (N = 100), La Paz (N = 75), Tijuana (N = 25) and rural communities (N = 50) to obtain information regarding allelic and haplotypic frequencies. The most frequent haplotypes for the Baja California region include nine Native American and five European haplotypes. Admixture estimates revealed that the main genetic components are European (50.45 ± 1.84% by ML; 42.03% of European haplotypes) and Native American (43.72 ± 2.36% by ML; 40.24% of Native American haplotypes), while the African genetic component was less apparent (5.83 ± 0.98% by ML; 9.36% of African haplotypes).

1 September 2020 in Human Immunology
Verified
Journal Article
Closed access
JPJorge Arturo Pantoja-Torres
Jorge Arturo Pantoja-Torres
RBRodrigo Barquera
Rodrigo Barquera
MBMónica Ballesteros-Romero
Mónica Ballesteros-Romero
ABAlicia Bravo-Acevedo
Alicia Bravo-Acevedo
EAEsteban Arrieta-Bolaños
Esteban Arrieta-Bolaños
JGJulio Granados
Julio Granados

22 April 2021 in Case Reports in Transplantation
Verified
Journal Article
Open access
PDF file
ARAna Paola Rico-Portillo
Ana Paola Rico-Portillo
JCJosé Ignacio Cerrillos-Gutierrez
José Ignacio Cerrillos-Gutierrez
Jorge Andrade SierraJorge Andrade Sierra
Jorge Andrade Sierra
AGAlfredo Gutiérrez-Govea
Alfredo Gutiérrez-Govea
EREnrique Rojas-Campos
Enrique Rojas-Campos
BGBenjamín Gómez-Navarro
Benjamín Gómez-Navarro
A 47-year-old male was diagnosed with chronic kidney disease (CKD) in 2011; idiopathic thrombocytopenic purpura (ITP) was also diagnosed in 2011 refractory to medical treatment and finally treated with splenectomy (2017) without relapses since that date, 5 blood transfusions, and 4 platelet apheresis in 2017. Renal transplant from a living related donor (brother), ABO compatible, crossmatch were negative, sharing 1 haplotype. Donor-specific anti-HLA antibody was negative. Graft function was stable until the 5th day and graft biopsy on the 6th day; thrombotic microangiopathy (TMA), C4D negative and inflammatory infiltration of polymorphonuclear leukocytes inside peritubular capillary, and anti-MICA antibodies were positive. The treatment used were plasmapheresis, intravenous immunoglobulin, and rituximab. Serum creatinine began to decrease since the 14th day, and by day 33, post-RT graft function was restored.